Latest Insider Transactions at Usana Health Sciences Inc (USNA)
This section provides a real-time view of insider transactions for Usana Health Sciences Inc (USNA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of USANA HEALTH SCIENCES INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of USANA HEALTH SCIENCES INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 23
2020
|
Paul A. Jones CHIEF PEOPLE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
178
-3.19%
|
$15,130
$85.86 P/Share
|
|
Oct 23
2020
|
Paul A. Jones CHIEF PEOPLE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
550
+8.97%
|
-
|
|
Oct 23
2020
|
Walter Noot CHIEF OPERATING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
280
-44.37%
|
$23,800
$85.86 P/Share
|
|
Oct 23
2020
|
Walter Noot CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
631
+50.0%
|
-
|
|
Oct 23
2020
|
Kevin Guest EXEC. CHAIRMAN OF THE BOARD |
SELL
Payment of exercise price or tax liability
|
Direct |
814
-24.75%
|
$69,190
$85.86 P/Share
|
|
Oct 23
2020
|
Kevin Guest EXEC. CHAIRMAN OF THE BOARD |
BUY
Exercise of conversion of derivative security
|
Direct |
1,835
+35.81%
|
-
|
|
Oct 23
2020
|
Joshua Foukas CHIEF LEGAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
118
-37.46%
|
$10,030
$85.86 P/Share
|
|
Oct 23
2020
|
Joshua Foukas CHIEF LEGAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
315
+50.0%
|
-
|
|
Oct 23
2020
|
David Mulham Mulham CHIEF SALES OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
638
+6.71%
|
-
|
|
Oct 23
2020
|
Robert A Sinnott CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
259
-44.89%
|
$22,015
$85.86 P/Share
|
|
Oct 23
2020
|
Robert A Sinnott CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
577
+50.0%
|
-
|
|
Oct 23
2020
|
Robert Auciaux |
SELL
Open market or private sale
|
Direct |
989
-69.89%
|
$84,065
$85.29 P/Share
|
|
Oct 22
2020
|
Robert A Sinnott CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
6,043
-100.0%
|
$495,526
$82.0 P/Share
|
|
Oct 22
2020
|
Robert A Sinnott CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
6,043
+50.0%
|
$392,795
$65.48 P/Share
|
|
Oct 22
2020
|
Feng Peng Director |
SELL
Open market or private sale
|
Direct |
330
-21.84%
|
$27,060
$82.81 P/Share
|
|
Oct 21
2020
|
Timothy E Wood Director |
BUY
Exercise of conversion of derivative security
|
Direct |
426
+50.0%
|
-
|
|
Oct 21
2020
|
Peggie Pelosi Director |
SELL
Payment of exercise price or tax liability
|
Direct |
187
-14.62%
|
$15,895
$85.39 P/Share
|
|
Oct 21
2020
|
Peggie Pelosi Director |
BUY
Exercise of conversion of derivative security
|
Direct |
426
+21.91%
|
-
|
|
Oct 21
2020
|
Gilbert A Fuller Director |
BUY
Exercise of conversion of derivative security
|
Direct |
426
+50.0%
|
-
|
|
Oct 21
2020
|
Robert Auciaux |
SELL
Payment of exercise price or tax liability
|
Direct |
128
-8.3%
|
$10,368
$81.5 P/Share
|
|
Oct 21
2020
|
Robert Auciaux |
BUY
Exercise of conversion of derivative security
|
Direct |
426
+21.64%
|
-
|
|
Oct 21
2020
|
Feng Peng Director |
BUY
Exercise of conversion of derivative security
|
Direct |
426
+21.99%
|
-
|
|
Oct 21
2020
|
Frederic J Winssinger Director |
BUY
Exercise of conversion of derivative security
|
Direct |
426
+23.96%
|
-
|